Omadacycline Suppliers & Bulk Manufacturers
Available Forms: Tablet/ Injection
Available Strengths: 100 mg, 150 mg
Reference Brands: Nuzyra (USA/EU)
Category: Antibiotics
Omadacycline is available in Tablet/ Injection and strengths such as 100 mg, 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Omadacycline is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Omadacycline can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Omadacycline is a broad-spectrum antibiotic used to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). It belongs to the aminomethylcycline subclass of tetracycline antibiotics and is effective against a wide range of Gram-positive and Gram-negative bacteria. Omadacycline works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and helping the body eliminate infection.
Sold under the brand name Nuzyra, omadacycline is available in both oral and intravenous formulations, offering flexibility for patient treatment and hospital settings. It is designed specifically to target bacterial infections and is not effective against viral infections such as colds or the flu. Approved in the United States in October 2018, omadacycline provides a valuable treatment option for patients who may have limited responses to other antibiotics. Its broad-spectrum activity, combined with its oral bioavailability and well-tolerated safety profile, makes it a preferred choice for physicians managing community-acquired pneumonia and skin infections.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Omadacycline is used for the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia in adults. It is effective against a wide range of Gram-positive and Gram-negative bacteria, including resistant strains.
Omadacycline is a semisynthetic aminomethylcycline antibiotic derived from the tetracycline class. Its complete generic name is omadacycline tosylate.
Omadacycline is marketed under the trade name Nuzyra.
Omadacycline was developed by Paratek Pharmaceuticals and is marketed by Paratek Pharmaceuticals, Inc. in multiple regions.
The generic name of Omadacycline is omadacycline tosylate.
The brand name of Omadacycline is Nuzyra.
Omadacycline is manufactured at GMP-compliant pharmaceutical facilities, primarily in the United States and Europe, depending on the market and supply chain.
Related Products
Nitrofurantoin
Strength:
25 mg, 50 mg, 100 mg
Form: Capsules
Reference Brands: Macrobid (USA), Macrodantin (USA)
View Details
Nafcillin
Strength:
500 mg, 1 g, 2 g
Form: Injection
Reference Brands: Generic formulations marketed under different names
View Details
Methenamine Hippurate
Strength:
1 g
Form: Tablets
Reference Brands: Hiprex (USA), Mandelamine (USA), Urex (USA)
View Details
Gatifloxacin
Strength:
0.3%
Form: Eye Drops / Tablets
Reference Brands: Zymar (USA), Zymaxid (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
